REGU-MATE GEL 2.15MG/G DIN 00870919
Health Canada record
| Active ingredient(s) | ALTRENOGEST 2.15 MG |
|---|---|
| Dosage form | Gel |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 05-Aug-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALTRENOGEST
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02464047 | ALTERMATE | ARIVAC INC. | Solution | ALTRENOGEST 2.2 MG | Approved |
| 02519135 | ALTREN SOLUTION 0.22% | AURORA PHARMACEUTICAL, INC. | Solution | ALTRENOGEST 2.2 MG | Marketed |
| 00641987 | REGU-MATE SOLUTION 0.22% | INTERVET CANADA CORP | Solution | ALTRENOGEST 2.2 MG | Marketed |
| 02454882 | ALTRESYN | CEVA ANIMAL HEALTH INC | Solution | ALTRENOGEST 2.2 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6495 | 2000-08-30 | New Drug Submission (NDS) | |
| 6589 | 1999-06-22 | New Drug Submission (NDS) |
International API supply for ALTRENOGEST
1 active FDA Drug Master Files.
Request a quote for REGU-MATE GEL 2.15MG/G